Skip to main content

Table 3 Factors predicting tumor response (multivariate analysis)

From: Interstitial lung disease in gefitinib-treated Japanese patients with non-small cell lung cancer – a retrospective analysis: JMTO LC03-02

Factor

No. patients

Odds ratio (95% CI)

p-value

Sex

   

   Male

256

1

-

   Female

152

4.35 (2.40–7.90)

<0.001

Prior chemotherapy

   

   No

82

1

-

   Yes

326

0.34 (0.18–0.65)

0.001

Absolute neutrophil count

408

0.85 (0.75–0.93)*

0.017

Histological type

   

   Non-adenocarcinoma

127

1

-

   Adenocarcinoma

281

2.35 (1.03–5.35)

0.043

  1. Valuables with p < 0.05 were selected using a backward elimination procedure.
  2. *per 1000/μL.